نتایج جستجو برای: anti cd45 antibody

تعداد نتایج: 480645  

2012
Antonio Giordano Hui Gao Simone Anfossi Evan Cohen Michal Mego Bang-Ning Lee Sanda Tin Michele De Laurentiis Charla A. Parker Ricardo H. Alvarez Vicente Valero Naoto T. Ueno Sabino De Placido Sendurai A. Mani Francisco J. Esteva Massimo Cristofanilli James M. Reuben

Currently, there is extensive information about circulating tumor cells (CTC) and their prognostic value; however, little is knownabout other characteristics of these cells. In thisprospective study,weassessed thegene transcripts of epithelial-to-mesenchymal transition—inducing transcription factors (EMT-TF) and cancer stem cell (CSC) features in patients with HER2þmetastatic breast cancer (MBC...

Journal: :Cancer research 2009
Hirohisa Nakamae D Scott Wilbur Donald K Hamlin Monica S Thakar Erlinda B Santos Darrell R Fisher Aimee L Kenoyer John M Pagel Oliver W Press Rainer Storb Brenda M Sandmaier

We previously investigated the potential of targeted radiotherapy using a bismuth-213 ((213)Bi)-labeled anti-CD45 antibody to replace total body irradiation as conditioning for hematopoietic cell transplantation in a canine model. Although this approach allowed sustained marrow engraftment, limited availability, high cost, and short half-life of (213)Bi induced us to investigate an alternative ...

Journal: :Blood 2011
John M Pagel Aimee L Kenoyer Tom Bäck Donald K Hamlin D Scott Wilbur Darrell R Fisher Steven I Park Shani Frayo Amanda Axtman Nural Orgun Johnnie Orozco Jaideep Shenoi Yukang Lin Ajay K Gopal Damian J Green Frederick R Appelbaum Oliver W Press

Pretargeted radioimmunotherapy (PRIT) using an anti-CD45 antibody (Ab)-streptavidin (SA) conjugate and DOTA-biotin labeled with β-emitting radionuclides has been explored as a strategy to decrease relapse and toxicity. α-emitting radionuclides exhibit high cytotoxicity coupled with a short path length, potentially increasing the therapeutic index and making them an attractive alternative to β-e...

2011
John M. Pagel Aimee L. Kenoyer Tom Bäck Donald K. Hamlin D. Scott Wilbur Darrell R. Fisher Steven I. Park Shani Frayo Amanda Axtman Nural Orgun Johnnie Orozco Jaideep Shenoi Yukang Lin Ajay K. Gopal Damian J. Green Frederick R. Appelbaum Oliver W. Press

Pretargeted radioimmunotherapy (PRIT) using an anti-CD45 antibody (Ab)–streptavidin (SA) conjugate and DOTA-biotin labeled with -emitting radionuclides has been explored as a strategy to decrease relapse and toxicity. -emitting radionuclides exhibit high cytotoxicity coupled with a short path length, potentially increasing the therapeutic index and making them an attractive alternative to -emit...

Journal: :international journal of preventive medicine 0
hosein saneian arash mansoor gorgani

background: celiac disease is one of the malabsorption syndromes leads to growth and development retardation in children. there is no test lonely can definitely diagnose celiac; however, the collection of clinical findings, serologic tests, intestinal biopsy, and response to treatment may diagnose it. although diagnostic value is variable in different studies, they are used a non-invasive and a...

Journal: :middle east journal of digestive diseases 0
azita ganji mohsen sadrneshin ali bahari abbas esmaeilzadeh kamran ghafarzadegan shafagh nikpour

background worldwide, the incidence of inflammatory bowel disease (ibd) is increasing. this study aims to evaluate the diagnostic value of two serological markers, atypical perinuclear anti-neutrophil cytoplasmic antibodies (atypical-p-anca) and anti-saccharomyces cerevisiae antibodies (asca), with the intent to determinetheir relationship to ulcerative colitis (uc) and crohn's disease (cd), in...

Journal: :Blood 2003
Shaji Kumar Teresa K Kimlinger John A Lust Kathleen Donovan Thomas E Witzig

Multiple myeloma (MM) and primary systemic amyloidosis (AL) remain incurable disorders, and new treatments targeted to the malignant plasma cells are needed. Alemtuzumab is a humanized monoclonal antibody to CD52 and has activity in chronic lymphocytic leukemia. We examined the CD52 expression on CD45+ and CD45- plasma cell populations to evaluate the potential for using alemtuzumab for these d...

Journal: :The Journal of Experimental Medicine 1990
T Mimura P Fernsten W Jarjour J B Winfield

Nearly one-third of IgM antilymphocyte autoantibody-positive sera from patients with systemic lupus erythematosus (SLE) contain IgM antibodies to one or more 180-220-kD molecules (p180, p190, p205, and p220) in blots of glycoproteins purified from T cells by wheat germ agglutinin affinity chromatography. Identity of these IgM targets with multiple isoforms of CD45 was established by their speci...

Journal: :Cancer research 2007
Yong Du Jamie Honeychurch Martin Glennie Peter Johnson Tim Illidge

Radioimmunotherapy is a highly effective treatment for some hematologic malignancies; however, the underlying mechanisms of tumor clearance remain poorly understood. We have previously shown that both targeted radiation using (131)I-labeled anti-MHC class II (MHCII) monoclonal antibody (mAb) plus mAb signaling with unlabeled anti-idiotype are required for the long-term clearance of tumor in syn...

Journal: :Investigative ophthalmology & visual science 2012
Shintaro Nakao Mitsuru Arima Keijiro Ishikawa Riichiro Kohno Shuhei Kawahara Masanori Miyazaki Shigeo Yoshida Hiroshi Enaida Ali Hafezi-Moghadam Toshihiro Kono Tatsuro Ishibashi

PURPOSE Anti-VEGF-A antibody (Ab) (e.g., bevacizumab, ranibizumab) is widely used as a treatment against retinal angiogenesis and edema. The purpose of this study was to evaluate whether intravitreal anti-VEGF Ab injection modulates inflammatory cells in retinal angiogenesis. METHODS To investigate whether intravitreal bevacizumab injections affect the number of inflammatory cells in prolifer...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید